Frontiers in Oncology,
Год журнала:
2025,
Номер
15
Опубликована: Фев. 26, 2025
Radioresistance
remains
a
predominant
factor
contributing
to
local
recurrence
in
esophageal
squamous
cell
carcinoma
(ESCC).
SATB2,
as
transcriptional
co-gene,
may
affect
the
radioresistance
of
cancer
cells.
Consequently,
this
study
aims
elucidate
mechanism
by
which
SATB2
modulates
radiotherapy
resistance
cancer.
We
identified
highly
expressed
genes
associated
with
ESCC
using
MSigDB
database
and
conducted
survival
correlation
analysis.
A
radioresistant
line
(KYSE150R)
was
established
gradient
dose
method,
RT-qPCR
used
detect
expression
KYSE150
KYSE150R
CCK-8,
Transwell,
colony
formation
assay,
scratching
were
performed
determine
evaluate
proliferation,
migration,
invasion.
Furthermore,
levels
mRNA
protein
correlated
WB
RT-qPCR.
Mitochondrial
membrane
potential
apoptosis
detection
kits
level
apoptosis.
Finally,
mouse
subcutaneous
xenograft
tumor
model
employed
role
on
vivo.
Bioinformatics
analysis
indicated
that
is
linked
increased
drug
The
results
demonstrated
suppression
decelerates
proliferation
accelerates
apoptosis,
inhibits
GSK-3β
(Ser9)
phosphorylation,
reduces
β-catenin
target
gene
C-myc.
addition
Wnt/β-catenin
signaling
pathway
agonist
(CHIR-99021)
reversed
these
effects.
Xenograft
studies
mice
revealed
knockdown
reduced
radioresistance.
concluded
dysregulate
pathway,
thereby
facilitating
EMT
progression
conferring
Advanced Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 5, 2024
Radiotherapy
(RT),
essential
for
treating
various
cancers,
faces
challenges
from
tumor
hypoxia,
which
induces
radioresistance.
A
tumor-targeted
"prosthetic-Arginine"
coassembled
nanozyme
system,
engineered
to
catalytically
generate
nitric
oxide
(NO)
and
oxygen
(O
Antioxidants,
Год журнала:
2024,
Номер
13(7), С. 778 - 778
Опубликована: Июнь 27, 2024
Antioxidants
play
a
pivotal
role
in
neutralizing
reactive
oxygen
species
(ROS),
which
are
known
to
induce
oxidative
stress.
In
the
context
of
cancer
development,
cells
adeptly
maintain
elevated
levels
both
ROS
and
antioxidants
through
process
termed
"redox
reprogramming".
This
balance
optimizes
proliferative
influence
while
simultaneously
reducing
potential
for
cause
damage
cell.
some
cases,
adapted
antioxidant
machinery
can
hamper
efficacy
treatments
neoplastic
diseases,
representing
significant
facet
resistance
mechanisms
observed
therapy.
this
review,
we
outline
contribution
systems
therapeutic
resistance.
We
detail
fundamental
constituents
these
systems,
encompassing
central
regulatory
involving
transcription
factors
(of
particular
importance
is
KEAP1/NRF2
signaling
axis),
molecular
effectors
antioxidants,
auxiliary
responsible
NADPH
generation.
Furthermore,
present
recent
clinical
trials
based
on
targeted
treatment
cancer,
assessing
as
well
challenges
strategy
Additionally,
summarize
pressing
issues
field,
with
aim
illuminating
path
toward
emergence
novel
anticancer
approaches
by
orchestrating
redox
signaling.
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Фев. 23, 2024
Gastrointestinal
(GI)
tumors
are
a
significant
global
health
threat,
with
high
rates
of
morbidity
and
mortality.
Exosomes
contain
various
biologically
active
molecules
like
nucleic
acids,
proteins,
lipids
can
serve
as
messengers
for
intercellular
communication.
They
play
critical
roles
in
the
exchange
information
between
tumor
cells
microenvironment
(TME).
The
TME
consists
mesenchymal
components
extracellular
matrix
(ECM),
fibroblasts
being
most
abundant
cell
type
mesenchyme.
Cancer-associated
(CAFs)
derived
from
normal
stem
that
activated
TME.
CAFs
secrete
exosomes
to
modulate
proliferation,
invasion,
migration,
drug
resistance,
other
biological
processes
tumors.
Additionally,
manipulate
function
behavior
through
direct
cell-cell
interactions.
This
review
provides
summary
crosstalk
GI
exosomes,
along
potential
underlying
mechanisms.
As
one
part
of
the
innate
immune
response
to
external
stimuli,
chronic
inflammation
increases
risk
various
cancers,
and
tumor-promoting
is
considered
enabling
characteristics
cancer
development.
Recently,
there
has
been
growing
evidence
on
role
anti-inflammation
therapy
in
prevention
treatment.
And
researchers
have
already
achieved
several
noteworthy
outcomes.
In
review,
we
explored
underlying
mechanisms
by
which
affects
occurrence
development
cancer.
The
pro-
or
anti-tumor
effects
these
inflammatory
factors
such
as
interleukin,
interferon,
chemokine,
inflammasome,
extracellular
matrix
are
discussed.
Since
FDA-approved
drugs
like
aspirin
show
obvious
effects,
unique
advantages
due
their
relatively
fewer
side
with
long-term
use
compared
chemotherapy
drugs.
make
them
promising
candidates
for
chemoprevention.
Overall,
this
review
discusses
molecules
carcinogenesis
new
molecules-directed
therapeutic
opportunities,
ranging
from
cytokine
inhibitors/agonists,
inflammasome
inhibitors,
some
inhibitors
that
expected
be
applied
clinical
practice,
well
recent
discoveries
effect
non-steroidal
anti-inflammatory
steroidal
disadvantages
application
chemoprevention
also
Abstract
In
the
progression
of
X‐ray‐based
radiotherapy
for
treatment
cancer,
incorporation
nanoparticles
(NPs)
has
a
transformative
impact.
This
study
investigates
potential
NPs,
particularly
those
comprised
high
atomic
number
elements,
as
radiosensitizers.
aims
to
optimize
localized
radiation
doses
within
tumors,
thereby
maximizing
therapeutic
efficacy
while
preserving
surrounding
tissues.
The
multifaceted
applications
NPs
in
encompass
collaborative
interactions
with
chemotherapeutic,
immunotherapeutic,
and
targeted
pharmaceuticals,
along
contributions
photodynamic/photothermal
therapy,
imaging
enhancement,
integration
artificial
intelligence
technology.
Despite
promising
preclinical
outcomes,
paper
acknowledges
challenges
clinical
translation
these
findings.
conclusion
maintains
an
optimistic
stance,
emphasizing
ongoing
trials
technological
advancements
that
bolster
personalized
approaches.
advocates
continuous
research
validation,
envisioning
revolutionary
paradigm
cancer
ultimately
enhancing
patient
outcomes.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Янв. 16, 2024
Background
While
simultaneous
chemoradiotherapy
remains
the
established
therapeutic
modality
for
patients
afflicted
with
locally
advanced
esophageal
cancer,
effectiveness
of
this
radical
approach
falls
short
desired
outcome.
Numerous
investigations
have
illuminated
prospect
enhancing
efficacy
through
amalgamation
and
immunotherapeutic
interventions.
Consequently,
we
embarked
on
an
examination
to
scrutinize
potential
survival
advantages
conferred
by
confluence
immunotherapy
in
relation
unresectable
carcinoma,
drawing
upon
extensive
SEER
database
our
analysis.
Methods
We
extracted
clinicopathological
attributes
statistics
diagnosed
within
temporal
span
encompassing
years
2004-2014
2019-2020,
from
database.
To
discern
disparities
both
overall
(OS)
cancer-specific
(CSS)
between
cohorts
subjected
combined
alone,
employed
analytical
tools
such
as
Kaplan-Meier
analysis,
Log-rank
test,
Cox
regression
proportional
risk
model,
propensity-matched
score
(PSM)
methodology.
Results
A
total
7,758
eligible
were
encompassed
research,
6,395
individuals
having
undergone
while
1,363
received
treatment
immunotherapy.
After
1:4
propensity
matching,
6,447
successfully
harmonized,
yielding
a
well-balanced
cohort.
The
curves
demonstrated
substantial
enhancement
OS
(P
=
0.0091)
CSS
<
0.001)
group
compared
alone.
Further
multivariable
analysis
PSM
confirmed
that
benefits
OS(HR=0.89,
95%
CI
0.81-0.98)
(HR=0.68,
0.61-0.76).
In
addition,
Univariable
analyses
matched
patient
groups
unveiled
several
independent
prognostic
factors
CSS,
including
sex,
age,
marital
status,
tumor
location,
size,
pathologic
grade,
historic
staging,
modality.
Among
these
factors,
being
female,
married,
receiving
emerged
protective
age
exceeding
75
years,
non-superior
segment
size
greater
than
6
cm,
Grade
3-4
pathology,
regional
staging
all
found
be
factors.
advantage
over
alone
was
substantial.
Conclusions
This
investigation
furnishes
compelling
evidence
integration
confers
noteworthy
when
contrasted
conventional
grappling
carcinoma.
International Journal of General Medicine,
Год журнала:
2025,
Номер
Volume 18, С. 415 - 436
Опубликована: Янв. 1, 2025
Crotonylation
is
an
emerging
lysine
acylation
modification
implicated
in
various
diseases,
yet
its
role
esophageal
squamous
cell
cancer
(ESCC)
unexplored.
This
study
aimed
to
investigate
the
of
crotonylation-related
genes
(CRGs)
ESCC
using
bioinformatics
approaches.
We
included
three
datasets
and
24
CRGs.
Differentially
expressed
(DEGs)
from
TCGA-ESCA
were
intersected
with
key
module
related
CRGs
identify
candidate
genes.
Univariate
LASSO
regression
analyses
conducted
select
prognostic
genes,
which
then
used
construct
risk
models.
Independent
analysis
nomogram
construction
followed.
Functional
enrichment
immune
infiltration
performed
Single-cell
was
assess
communication
pseudotemporal
dynamics
cells.
Intersection
1529
DEGs
1,048
yielded
55
OSM,
FABP3,
MICB,
FAM189A2
identified
as
These
classify
ESCA
patients
into
different
groups
a
nomogram.
FABP3
enriched
neuroactive
ligand-receptor
interaction
ribosome
terms.
MICB
showed
strong
positive
correlations
natural
killer
T
(NKT)
cells,
while
negatively
correlated
gamma
delta
(γδT)
mast
cells
neutrophils
differentiating
seven
states,
respectively.
Four
(OSM,
FAM189A2)
ESCC,
potentially
involved
pathogenesis.
OSM
positively
correlated.